Page 119 - Read Online
P. 119
Page 113 Chu et al. J Transl Genet Genom 2023;7:196-212 https://dx.doi.org/10.20517/jtgg.2023.22
25. BBMRI-ERIC. Turkish genome project launched. Available from: https://www.bbmri-eric.eu/news-events/turkish-genome-project-
launched/ [Last accessed on 23 Oct 2023].
26. Özçelik T. Medical genetics and genomic medicine in Turkey: a bright future at a new era in life sciences. Mol Genet Genomic Med
2017;5:466-72. DOI PubMed PMC
27. Chung CCY, Hong Kong Genome Project, Chu ATW, Chung BHY. Rare disease emerging as a global public health priority.
Front Public Health 2022;10:1028545. DOI PubMed PMC
28. Chung BHY, Chau JFT, Wong GK. Rare versus common diseases: a false dichotomy in precision medicine. NPJ Genom Med
2021;6:19. DOI PubMed PMC
29. Posey JE, O’Donnell-Luria AH, Chong JX, et al. Insights into genetics, human biology and disease gleaned from family based
genomic studies. Genet Med 2019;21:798-812. DOI
30. Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature
2020;581:434-43. DOI
31. Census and statistics department, Hong Kong special administrative region. Table 150-11001: projected mid-year population by sex
and age group. Available from: https://www.censtatd.gov.hk/en/web_table.html?id=150-11001 [Last accessed on 23 Oct 2023].
32. Census and statistics department, Hong Kong special administrative region. 2016 population by-census: summary results. Available
from: https://www.bycensus2016.gov.hk/data/16bc-summary-results.pdf [Last accessed on 23 Oct 2023].
33. The steering committee of genomic medicine, Hong Kong special administrative region. Strategic development of genomic medicine
in Hong Kong. 2022. Available from: https://www.healthbureau.gov.hk/download/press_and_publications/otherinfo/200300_genomic/
SCGM_report_en.pdf [Last accessed on 23 Oct 2023].
34. Hong Kong genome institute. strategic plan 2022-25. Available from: https://hkgp.org/ebook/HKGI-Strategic-Plan/ [Last accessed on
23 Oct 2023].
35. Van der Auwera G, O’Connor B. Genomics in the cloud: using docker, GATK, and WDL in Terra, 1st edition. Sebastopol, CA:
O'Reilly Media 2020.
36. Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. 2013. Available from: https://ui.adsabs.
harvard.edu/abs/2013arXiv1303.3997L/abstract [Last accessed on 23 Oct 2023].
37. Picard tools. Version 2.17.8. Broad institute, GitHub repository. Available from: http://broadinstitute.github.io/picard/ [Last accessed
on 23 Oct 2023].
38. McLaren W, Gil L, Hunt SE, et al. The ensembl variant effect predictor. Genome Biol 2016;17:122. DOI PubMed PMC
39. Danecek P, Bonfield JK, Liddle J, et al. Twelve years of SAMtools and BCFtools. Gigascience 2021;10:giab008. DOI PubMed PMC
40. Smedley D, Jacobsen JO, Jäger M, et al. Next-generation diagnostics and disease-gene discovery with the Exomiser. Nat Protoc
2015;10:2004-15. DOI PubMed PMC
41. Martin AR, Williams E, Foulger RE, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels.
Nat Genet 2019;51:1560-5. DOI
42. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus
recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med
2015;17:405-24. DOI PubMed PMC
43. Hall L, Wilson JA, Bernard K, et al. Establishing molecular testing in clinical laboratory environments; Proposed guideline. 2011.
Available from: https://clsi.org/media/1474/mm19a_sample.pdf [Last accessed on 23 Oct 2023].
44. Aysal A, Pehlivanoglu B, Ekmekci S, Gundogdu B. How to set up a molecular pathology lab: a guide for pathologists. Turk Patoloji
Derg 2020;36:179-87. DOI PubMed PMC
45. Marshall CR, Chowdhury S, Taft RJ, et al. Best practices for the analytical validation of clinical whole-genome sequencing intended
for the diagnosis of germline disease. NPJ Genom Med 2020;5:47. DOI PubMed PMC
46. Aziz N, Zhao Q, Bry L, et al. College of American pathologists’ laboratory standards for next-generation sequencing clinical tests.
Arch Pathol Amp Lab Med 2015;139:481-93. PubMed
47. Bogdanova N, Markoff A, Gerke V, McCluskey M, Horst J, Dworniczak B. Homologues to the first gene for autosomal dominant
polycystic kidney disease are pseudogenes. Genomics 2001;74:333-41. DOI
48. Hübschmann D, Schlesner M. Evaluation of whole genome sequencing data. Methods Mol Biol Clifton N J 2019;1956:321-36. DOI
49. Ribarska T, Bjørnstad PM, Sundaram AYM, Gilfillan GD. Optimization of enzymatic fragmentation is crucial to maximize genome
coverage: a comparison of library preparation methods for Illumina sequencing. BMC Genom 2022;23:92. DOI PubMed PMC
50. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ. Amplification-free Illumina sequencing-library preparation
facilitates improved mapping and assembly of (G+C)-biased genomes. Nat Methods 2009;6:291-5. DOI PubMed PMC
51. Quail MA, Swerdlow H, Turner DJ. Improved protocols for the illumina genome analyzer sequencing system. Curr Protoc Hum Genet
2009;62:18.2.1-27. DOI PubMed
52. Rehm HL, Page AJH, Smith L, et al. GA4GH: international policies and standards for data sharing across genomic research and
healthcare. Cell Genom 2021;1:100029. DOI
53. Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med
2016;18:696-704. DOI
54. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA
2014;312:1880-7. DOI PubMed PMC